Product Information
Name:Tipifarnib
Synonyms:
- 6-[(R)-Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinoneZarnestra
Brand:Biosynth
Description:Tipifarnib is a farnesyltransferase inhibitor, which is a synthetic compound designed for experimental cancer treatment. It functions by targeting farnesyltransferase, an enzyme involved in the post-translational modification of proteins through the attachment of a farnesyl group to the protein's cysteine residue. This modification is crucial for the activity of several proteins, including those in the Ras signaling pathway, which is often dysregulated in cancer.
By inhibiting farnesyltransferase, Tipifarnib prevents the proper functioning of these proteins, thereby disrupting key signaling pathways that are essential for cancer cell proliferation and survival. This makes it a molecule of significant interest in oncology research, particularly in cancers with mutations that lead to increased Ras activity.
Tipifarnib has shown promise in the treatment of various malignancies, including particular types of leukemias and solid tumors. Its efficacy as a targeted therapy reflects its potential to selectively interfere with cancer growth while minimizing damage to normal cells. The ongoing research into its applications highlights its importance in the development of more effective, less toxic cancer treatments.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:489.4 g/mol
Formula:C27H22Cl2N4O
Purity:Min. 95%
Technical inquiry about: Tipifarnib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.